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SPANISH NANOMEDICINE PLATFORM 
 
The Spanish NanoMedicine Platform (SNMP) is an initiative of industries and 
research centres applying nanotechnologies for medical applications, supported by the 
Spanish government through the Centre for Industrial Technology Development 
(CDTI), in the context of the “nanotechnology action” of the Spanish Ministry of 
Education and Science (MEC), Ministry of Industry, Tourism and Trade (MICyT) and 
Ministry of Health. More than 70 groups are actually members of the Platform. 
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The policy objectives of the Spanish NanoMedicine Platform are: 
• Set-up a “unique window” for the Nanomedicine  community in Spain, 
• Improve the collaboration of the Spanish Nanomedicine community in 
international initiatives, from transnational cooperations to European projects, 
especially regarding the establishment of the European Technology Platforms, 
• Establish recommendations concerning strategic research lines in the 
Nanomedicine field,  
• Act as a community regarding the whole society concerning Nanomedicine 
aspects. 
 
The Spanish NanoMedicine Platform has divided its activity in five strategic priorities: 
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1- Nanodiagnostics  
2- Regenerative Medicine  
3- Drug Delivery 
4- Toxicity and Regulation  
5- Training and Communication 
Participion in the Working Groups
Regenerative 
Medicine
20%
Drug Delivery
25%
Toxicity/ 
Regulation
14%
Training/ 
Communic.
10%
Nano-
diagnostics
32%
 
 
 
Each working group is drawing up a report focused on the state of Nanomedicine in 
Spain in order to establish the areas where Spanish competences and expertise are 
well positioned at European level. The objective of those papers is also to open 
recommendations to the Spanish government which aim is to strongly support 
Nanomedicine initiatives.  
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